Descending
|
07/28/2011 More Than Just Cancer: Some Biomarkers Move Toward Validation
Chemical & Engineering News interviewed Mark Frasier, Director of Research Programs, on PPMI.
07/27/2011 Baylor College of Medicine Teams up with Michael J. Fox to Unravel the Deadly Mysteries of Parkinson's
In this special editorial series, CultureMap reported on Baylor College of Medicine in Houston, Texas--a PPMI site.
07/18/2011 Oklahoma Couple Come to Texas to Help Fight Parkinson's
KPRC-TV (Houston, TX) -
Every three to six months, Martin and GayLynn Bullock drive nine hours from Sweetwater, Oklahoma to Houston for their PPMI visits.
06/19/2011 Cleveland Clinic Picked for Study in Parkinson's
TribLive News -
Local coverage on the selection of the Cleveland Clinic as a PPMI site.
06/13/2011 Marching Through Life with Parkinson's
Jane Brody, personal health columnist for The New York Times, writes about ways to take control of your PD symptoms, from exercising to seeing a movement disorder specialist to participating in clinical research.
05/29/2011 Man Helps Friend by Volunteering for Parkinson's Study
WGRZ-TV, Buffalo, NY -
Local coverage of PPMI participant Paul Cohen and his friend with Parkinson's, Dave Wolf.
05/16/2011 Parkinson's Disease Researchers in Cleveland Play Important Role in Hunt for Cure
The Plain Dealer -
According to Todd Sherer, PhD, PD's prevalence is a "sort of major ticking time-bomb situation." Read a full report by Sarah Jane Tribble on Parkinson's and PPMI in Cleveland.
04/26/2011 UC San Diego Parkinson's Study
KUSI News Health Report -
KUSI News reported on the upcoming PPMI site at UCSD.
04/10/2011 Karen and Marc Jaffe on Fox & Friends
Fox & Friends -
In observation of Parkinson's Awareness Month, Karen and Marc Jaffe sit down with Alisyn Camerota on Fox & Friends to discuss their involvement in PPMI and The Michael J. Fox Foundation. Segment aired live on Sunday April 10, 2011.
04/08/2011 Lack of Biomarkers Makes it Tough to Target Parkinson's
San Diego Union-Tribune -
A Q&A with Dr. Douglas Galasko gives a background on Parkinson's, introduces PPMI and mentions the site at UCSD.
02/23/2011 Blick in die Zukunft von Parkinson
Tiroler Tageszeitung -
Austrian newspaper Tiroler Tageszeitung reported on PPMI in Innsbruck, Austria.
02/16/2011 Shaking with Laughter: Team Fox Members Karen and Marc Jaffe Prove an Inspiration in Their Fight Against PD
WKYC -
WKYC's Jennifer Lindgren reports on PPMI in Cleveland, OH and Karen Jaffe, a renowned local OBGYN with PD who is raising awareness of the cause, along with her husband.
12/21/2010 WGBH's 'The Point with Mindy Todd' Talks to Sam Frank, Site Investigator, PPMI at Boston University Medical Center
The Point with Mindy Todd -
Dr. Samuel Frank, Site Principal Investigator of PPMI at Boston University Medical Center, talks to WGBH-Boston about the search for a biomarker of PD.
12/15/2010 Fox Makes Plea for More Open-Source Biomarker Efforts
FierceBiomarkers.com -
FierceBiomarkers comments on Michael J. Fox's Op-Ed advocating for more resources to support open-source biomarker development efforts.
12/11/2010 Volunteers Help Make Parkinson's Research Possible
Houston Chronicle -
In an opinion piece for the Houston Chronicle, Michael J. Fox discusses PPMI and the importance of participation in clinical studies.
12/02/2010 Michael J. Fox Foundation Nears Funding Goal on Parkinson's Progression Markers Initiative
Dow Jones Newswire -
The Michael J. Fox Foundation is making good progress on signing up drug makers to a major new effort to identify biological signals that could prove crucial to developing new treatments for Parkinson's disease.
11/19/2010 Biomarker Promise for Parkinson's Disease
Lancet Neurology -
In a foreword to a special edition on Parkinson's biomarker research, UK scientific journal Lancet Neurology writes: "Only time will tell whether the PPMI will fulfill its promise... to improve research and treatment prospects for patients with PD, but we have reason to be optimistic."
10/15/2010 Boston University Medical Center Focusing in on Parkinson’s
The South End News -
BU researchers will spend the next five years tracking disease characteristics.
10/13/2010 Northwestern Seeks Clues to Parkinson's
Chicago Tribune -
Study searches for biomarker to help diagnose disease
09/29/2010 Parkinson's Biomarker Study
Crain's Health Pulse -
The Manhattan-based Michael J. Fox Foundation launched the Parkinson's Progression Markers Initiative, the first large-scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.
09/29/2010 Chicago Among Sites for Major Study on Parkinson's Disease
The News Gazette -
A five-year study is being kicked off at 18 research sites around the world, including one in Chicago, to speed up the development of treatments to slow or stop the progression of Parkinson's disease.
09/29/2010 Boston to Play Role in Parkinson's Fight (VIDEO)
WCVB-TV -
Actor Michael J. Fox is arguably the most high profile American living with Parkinson's Disease. Now his Foundation is sponsoring important research to help cure the disease and Boston is playing a big role.
09/29/2010 Michael J. Fox Grant for Boston University
Boston Metro -
The Michael J. Fox Foundation chose Boston University Medical Center as one of 18 official study sites for a landmark clinical study.
09/28/2010 MIchael J. Fox Foundation Launches Parkinson's Progression Markers Initiative (PPMI)
Landmark five-year $40-million global research study aims to identify biomarkers of Parkinson’s disease progression, critical tools for drug development
09/28/2010 Fact Sheet: Parkinson's Progression Markers Initiative
Read a fact sheet with basic information and details on PPMI.
09/27/2010 Banner Sun Health Research Institute Gains Major Parkinson’s Partner
Daily News-Sun -
The Michael J. Fox Foundation and the Banner Sun Health Research Institute are partnering in a breakthrough program geared toward searching for indicators of Parkinson’s disease.
08/23/2010 UAB Part of $40 Million Parkinson's Study
The Birmingham News -
The University of Alabama at Birmingham is a clinical site for PPMI, MJFF's landmark study to find biomarkers of Parkinson's disease.
08/19/2010 David Standaert, MD, Discusses PPMI in Birmingham on WBRC
MyFoxAl.com -
David Standaert, principal investigator of the Parkinson's Progression Markers Initiative at the University of Alabama Birmingham, discusses the study with Rick Journey on WBRC.
08/13/2010 Rare Sharing of Data Leads to Progress on Alzheimer’s
The New York Times -
The Parkinson’s Progression Markers Initiative, MJFF’s landmark clinical study aiming to identify biomarkers that reveal the progression of PD, is reported in the New York Times. Biomarkers are critical to developing long-awaited disease-modifying treatments that will transform patients’ lives.
08/11/2010 News in Context: Alzheimer's and Parkinson's Biomarkers Make Headlines
Todd Sherer, PhD, the Foundation’s vice president, research programs, discussed major biomarkers news reported this week -- and how the findings are bringing us closer to life-transforming treatments for Parkinson’s disease.
07/30/2010 News in Context: New Guidelines for Alzheimer's Disease Diagnosis
A New York Times article discusses the impact of biomarkers on criteria for Alzheimer’s disease diagnosis. Dr. Ken Marek, principal investigator of PPMI, discusses how PD biomarkers will impact diagnosis and treatment as well as drug development.
07/13/2010 A $2.5 Million Gift to Chart, Conquer Parkinson's
Wall Street Journal -
The Wall Street Journal's "Donor of the Day" column features Mrs. Lily Safra's $2.5 million gift to MJFF to support the Parkinson's Progression Markers Initiative.
07/13/2010 Mrs. Lily Safra's Lead Gift of $2.5 Million to Support Landmark Study to Find Biomarkers of Parkinson's Disease
Philanthropist Lily Safra's gift will support the Parkinson’s Progression Markers Initiative (PPMI). Mrs. Safra’s commitment will help galvanize the search for a biomarker of Parkinson’s disease progression.
04/21/2010 MJFF Launches Parkinson's Progression Markers Initiative (PPMI)
The groundbreaking, $40 million, five-year observational clinical study seeks to identify biomarkers of Parkinson’s disease.